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Attempts to comparatively analyse large-scale communicable disease control
programmes have, for the most part, neglected the wider health system contexts
within which the programmes lie. In addition, many evaluations of the
integration of vertical disease control programmes into health systems have
focused on single case studies or on a limited number of cases, or, when large
numbers of cases were drawn upon, have been presented as a compendium of
monographs rather than a systematic cross-national comparison. One reason for
this may be that appropriate theories and tools for comparative health systems
analysis are rare and difficult to formulate. In this paper we propose a
conceptual framework and an analytical methodology which might be used to
comparatively analyse a series of case studies that explore health systems,
communicable diseases programmes and concepts of integration in order to
make systematic comparisons to offer novel insights, to test new theories and to
offer new hypotheses. We illustrate through a preliminary analysis how this
framework can be applied to compare the impact of health systems integration
and HIV and TB programmes in four countries in South-East Asia that were the
subject of cases studies.
Keywords Comparative analysis, framework, Global Fund, health systems, integration,
methodology
Introduction
Attempts to comparatively analyse large-scale communicable
disease control programmes have, for the most part, neglected
the wider health system1 contexts within which the pro-
grammes lie (Coker et al. 2008). Whilst research into health
systems is an expanding field, a majority of analyses of health
systems fail to adequately address and compare elements
within the system, have encompassed limited numbers, or
types, of cases and lack a robust conceptual framework and
analytical methodology (Samb et al. 2009; de Savigny et al.
2009). Furthermore, most evaluations of the integration of
vertical disease control programmes into health systems have
focused on single case studies or on a limited number of cases,
and when large numbers of cases were used, these studies were
usually presented as a compendium of monographs rather than
a systematic cross-national comparison (Samb et al. 2009). One
reason for this, as suggested by the dearth of comparative
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analytical frameworks and methodologies, may be that appro-
priate theories and tools are rare and difficult to formulate.
There is an urgent need, hence, to develop a framework for
analysis that enables the systematic comparison of large
amounts of data and information from multiple case studies
in a robust, rigorous manner, in order to test new theories and
to offer new hypotheses. Indeed, in the case of the Global Fund
to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the
5-year review of the impact of Global Fund investments was,
despite being detailed and informative, limited analytically, in
part because its underlying theoretical framework was
undeveloped.
Here, we outline the development of a conceptual framework
and an analytical methodology to comparatively analyse a series
of country case studies commissioned by the Global Fund, in
order to evaluate the impact of the organization’s investment
in the control of HIV and tuberculosis (TB) on the health
system as a whole. The framework we propose describes how
communicable disease control programmes and health systems,
as well as the integration of the former into the latter, can be
conceptualized in order to make systematic comparisons of
several case studies, to test new theories and offer new
hypotheses. To ensure coherence, the work draws upon four
country case studies published in this supplement (Desai et al.
2010; Hanvoravongchai et al. 2010; Mounier-Jack et al. 2010;
Rudge et al. 2010). The framework also illustrates how a large
amount of data and information derived from multiple sources
can be condensed, measured and compared for analytic pur-
poses in a systematic manner. By systematic, we mean:
 An overall theory to govern analysis that provides testable
and deducible propositions for comparative examinations;
 Rigorous comparisons made through the use of common
categories, concepts or variables;
 The comparisons run throughout the body of work.
We present preliminary results based on examples from
four countries in South-East Asia: Indonesia, Lao People’s
Democratic Republic (Lao PDR), Papua New Guinea (PNG) and
Thailand.
Considerations in the development
of the framework
The analytical framework outlined in this paper employs a
mixed-methods approach, drawing upon both qualitative and
quantitative data. We have previously noted that fundamental
epistemological and ontological tensions can arise with research
that draws upon multiple disciplines, a tension manifest in
attempts to bridge fields that draw predominantly on either
qualitative or quantitative data, and this may be part of the
limitations of mixed-methods multidisciplinary research (Coker
et al. 2004). However, if the purpose of research and analysis is
to provide knowledge that can enhance the human condition,
‘the perfect’ should not be the enemy of ‘the good’. Putnam’s
groundbreaking work, for example, on social capital through
comparative analysis shows that it is possible to build robust
theories and conduct analyses that meaningfully inform
academic and policy debates (Putnam et al. 1995).
Insights gained from robust, systematic analyses are useful
even if the conceptual frameworks and analytical methodolo-
gies have limitations. Any comparative analysis must acknow-
ledge and attempt to address limitations that hinder the
development of a thorough understanding. This response can
include: (i) formulating a theory or building a conceptual and
analytical framework that can generate explanations or plaus-
ible hypotheses to be examined; (ii) overcoming contextual
variations that complicate meaningful comparisons; (iii) incor-
porating appropriate qualitative and quantitative data analytic-
ally; and (iv) collecting, processing and interpreting substantial
amounts of data.
First, frameworks offer one way of looking at the world.
In putting boundaries around constructs they are necessarily
selective, magnifying the importance of some information
whilst minimizing the importance of other information. As
such, no framework offers perfect insight, and all frameworks
will have relative merits and liabilities. The ultimate test of a
framework is whether it describes and explains an issue or
problem better or opens up new considerations compared with
existing frameworks.
Secondly, a comparative analysis should offer insights that
have meaning in a broad variety of contexts, that is, it must
capture contextual meaning. The difficulty in defining a
problem is necessarily subjective and any one definition may
not describe all case studies within the analysis. For example,
whilst multidrug-resistant tuberculosis (MDR-TB) may be
iatrogenic in nature (though person to person spread is also a
problem), erratic anti-TB drug administration may be framed in
many ways: as an issue of patient autonomy, as a departure
from accepted good professional clinical practice, as a logistical
issue in the procurement and delivery of drugs, as a criminal
justice problem, or as a financial system problem (Atun et al.
2005; Coker et al. 2008). Drug quality may also be an important
element, with counterfeit drugs increasingly challenging public
health control programmes. A comparative analysis must
therefore be structured around a framework that addresses
the same problem defined in the same way, whilst making
allowances for variations in the problem in different contextual
settings, thereby facilitating the ability to draw useful
generalizations.
Thirdly, a framework and methodology for comparative analysis
should employ concepts that are sensitive to both qualitative
and quantitative differences in case studies and their component
parts that might themselves be somewhat arbitrarily framed.
Lastly, comparative analysis of cases must be able to
systematically collect and analyse a large mass of data. As the
number of cases increases so too does the volume of evidence to
be gathered through document analysis, routine data review
and interviews. These data then need to be analysed and
reduced to key themes or variables, compressed so they can be
used and refined so they accurately reflect the variables to
be measured.
Conceptual framework
Theoretical background
Our conceptual framework builds upon: (a) the work Pawson
and Tilley (1997) presented in their book, Realistic
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Evaluation; (b) our earlier work extending Pawson and Tilley’s
work to encompass communicable disease control programmes
and heath systems through the Systemic Rapid Assessment
(SYSRA) of health interventions (Atun et al. 2004; Coker et al.
2004); and (c) our further development of an analytical
framework to conduct case studies on the integration of HIV/
AIDS and TB control programmes and general health systems
(Conseil et al. 2009). Pawson and Tilley (1997) attempted to
go beyond the traditional research question often asked of
programmes, that of asking simply whether a programme
works or not, and instead attempted to develop a conceptual
framework that provides an understanding of why a programme
works, for whom and in what circumstances. They suggested several
elements to evaluate a programme whilst acknowledging its
complexity and the environment within which it sits, including:
(i) context; (ii) epidemiological problem; (iii) intervention; (iv)
mechanism; (v) outputs; and (vi) outcomes.
First, context denotes the political, legislative, social, economic
and technological environments within which communicable
disease control programmes sit. This environment may be
global, regional, national or local. These contextual elements
may also be drivers, that is, forces that operate to provide the
initiative, resources and energy for the control of communicable
diseases. Together, these components are part of the enabling or
constraining environments, the foundation upon which a
programme’s success or failure ultimately depends.
Secondly, the epidemiological problem refers to infection levels
and various disease characteristics. For example, this might
relate to upstream risk factors such as the emergence of
drug-resistant strains of TB or HIV, or clusters of diseases in
congregate settings such as prisons and other institutions.
The third component is the intervention intended to serve
public health. For example, in TB control this could be the
DOTS strategy and its respective components. For HIV, this
might be the prevention of mother-to-child transmission
through the four-pronged approach, including the use of
antiretroviral therapy (ART). Many interventions are recom-
mended through clinical and policy guidelines and are
evidence-based, thus lending themselves to scrutiny against
gold standards.
The fourth element is the mechanism by which interventions
are delivered. It is the mechanisms within a programme,
required to function effectively, that are of critical interest in
this comparative analysis for they make interventions oper-
ational. Interventions are often the focus of much evidence,
through randomized controlled trials (RCTs) for example, yet
the mechanisms by which these interventions are provided
usually rest on a weaker evidence base. For example, a regular
supply of quality-assured anti-TB drugs (the intervention) is
a prerequisite for an effective control programme, yet ques-
tions remain regarding how this can best be achieved (the
mechanism).
The fifth element of the conceptual framework relates
to outputs. Outputs are public health concepts that can be
measured or determined and include equity, acceptability,
efficiency and effectiveness of the control programmes as a
result of interventions. In a successful and sustainable
programme, these outputs ideally result in outcomes, such
as reduced incidence of disease or decreased mortality.
A schematic representation of the overarching conceptual
framework is illustrated here using TB as an example
(Figure 1).
However, whilst the conceptual framework outlined above
and illustrated in Figure 1 addresses many of the more obvious
factors that inform the delivery of services in programmes, it
does not explicitly address two issues of interest that are
important in a comparative analysis of communicable disease
control programmes and health systems, namely health system
functions and integration.
Health system functions and interventions
Health system functions are essential to meeting health goals in
an effective, efficient and equitable manner. To evaluate health
system functions, we have further expanded Pawson and
Tilley’s framework by linking the health system functions
described by Atun et al. (2004) to the mechanisms described
above. Atun et al. (2004) previously defined six health system
functions: (i) stewardship and governance; (ii) financing;
(iii) planning; (iv) service delivery; (v) monitoring and evalu-
ation; and (vi) demand generation. These functions consist of
mechanisms that enable interventions to impact upon the
health of populations (Figure 2).
As mentioned earlier, these six health system functions affect
both disease-control programmatic success as well as broader
health systems performance. Whilst Figure 1 conceptualizes
health systems at the macro level through ‘context’, it also
addresses the micro level through defined interventions that
reach patients and populations. Figure 2, through the incorp-
oration of health system functions, introduces the potential for
meso level analysis, thus providing a holistic ‘programme to
general health system’ conceptual framework. Figure 3 shows
the six health systems functions related both to programmes
and to the general health system, illustrated here by HIV and
TB control programmes. These functions were the focus of
analyses of integration between health systems and disease
control programmes in the case studies’ development (Desai
et al. 2010; Mounier-Jack et al. 2010; Rudge et al. 2010;
Hanvoravongchai et al. 2010)2. The analyses were conducted
using an interview guide developed in July 2009, which served
as the main tool to collect primary data in order to evaluate the
extent and nature of integration of Global Fund programmes
into national HIV and TB programmes, integration of the
national HIV and TB programmes into the general health
systems, and system-wide effects of Global Fund support on the
health system. This guide built on the guide developed for a
Vietnam case study (which focused mainly on integration of
diseases programmes into the health system, without specific
assessment of Global Fund support) also published in this
supplement (Conseil et al. 2010).
Integration
In recent years, along with a revitalized enthusiasm for
strengthening health systems, a debate has ensued about the
relative benefits or detrimental effects of integrating disease
control programmes that emphasize specific interventions, such
as those for HIV, TB, malaria and vaccine-preventable infections
and diseases, into mainstream health systems. The purpose
of integrating programmes into broader health systems is to
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benefit public health through more effective, efficient, equitable
and acceptable systems. Because the evidence base on the
benefits of integration of programmes and health systems is
weak, and because in recent years considerable investment
through global health initiatives has occurred, there is a need to
determine in a systematic fashion the extent and impact of
integration of programmes and health systems.
For the purpose of this analysis, we suggest that the term
‘integration’ represents a spectrum of organizational arrange-
ments related to the funding, administration, organization,
service delivery and clinical scenarios designed to create
connectivity, alignment and collaboration (Kodner and
Spreeuwenberg 2002). The spectrum of integration ranges
from no integration, to partial integration, to full integration,
Figure 1 Schematic representation of the conceptual framework with tuberculosis as an illustrative example.
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and can be conceptualized as occurring to various degrees,
across each of the different health system functions. The
literature on integration is reviewed by Shigayeva et al. in this
supplement (Shigayeva et al. 2010). Assessments of integration
within several countries in South East Asia are also published
in this supplement (Conseil et al. 2010; Desai et al. 2010;
Hanvoravongchai et al. 2010; Mounier-Jack et al. 2010; Rudge
et al. 2010; Tra¨ga˚rd and Shrestha 2010).
Proposed analytical methods for comparative
analysis
The seven domains that offer areas for comparative analyses
of case studies as described above include:
(1) Context
(2) Epidemiological problem
(3) Interventions
Figure 2 Schematic representation of health system functions and their linkage through mechanisms to interventions.
Figure 3 Schematic representation of health system functions at the general health system level and programmatic level.
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(4) Mechanisms
(5) Public health functions and levels of integration
(6) Outputs
(7) Outcomes.
The proposed framework thus consists of seven fairly distinct
domains, albeit interdependent and somewhat artificially
divided. These domains can be compared across each case
study. In particular, attention should be paid to public health
functions and their levels of integration, this being the focus
of the country case studies. In order to further explore the
relationships between context and public health functions
(and thereby their influences on mechanisms and interven-
tions), we may define two broad categories: (i) driving variables;
and (ii) steering variables.
By driving variables we mean in-country or global-level
variables that provide the initiative, resources and energy for
health systems development and integration where deemed
likely to offer benefits. As a driving force, for example, Global
Fund support provides the financing that is essential for
programme development. Political leadership in identifying
and prioritizing a specific disease to be addressed by govern-
ment policy is another example. Steering variables, on the other
hand, are likely to be predominantly domestic in origin and
give expression to whether, where and how control efforts are
energetically pursued, and whether integration of health system
functions is a notion that is embraced and encouraged in
pursuit of the effective deployment of mechanisms and inter-
ventions. Steering variables are likely to sit with programme
and general health system functions. An example might be
joint HIV and TB control planning meetings at national and
local levels. Figure 4 illustrates the schematic relationship
between driving and steering variables with other variables.
Integration scores
In this preliminary analysis we determine the degree of integra-
tion among health system functions between control pro-
gramme and health system. Drawing upon the approach used
in the country case studies from South East Asia, we construct
‘indicators’ that enable us to generate an index of relative
scoring of different countries, drawing upon a combination
of quantitative and qualitative data. The scale is ordinal, from
0 (no integration) to 2 (full integration) for each control
programme and system function. The values do not imply
support or even benefit gained, but merely the level of integration
either between a programme and the general health system or
between various programmes. These values can be compared
across countries, whilst acknowledging and describing country
differences across other variables, such as interventions, mech-
anisms, outputs and outcomes.
Importantly, the scores are a way of capturing differences in
levels of integration and carry no connotations or implications
regarding quality of care, efficiency, equity or even whether
integration is a beneficial component to achieving public health
goals. This noted, however, we can rank countries across
variables and present plausible models of how different levels
of integration are associated with outputs and outcomes given
different/similar contextual settings, epidemiological patterns of
disease, interventions and mechanisms.
In order to offer insights into national patterns we propose an
analytic extension. By discerning patterns through correlations
Figure 4 Schematic representation of the conceptual relationship between ‘domains’.
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between the impact on diseases, investments in HIV and TB
programmes, associations with a wider range of morbidity
indicators in public health areas not directly associated with
substantial programmatic investments, trends that suggest
associations with integration of health systems can be explored.
It may be possible to quantitatively infer benefits, detrimental
effects or a lack of correlation, and draw lessons from models
of integration, develop hypotheses and test theories. Moreover,
the strength of linkages among programmes and between
programmes and the general health system can thus be
analysed collectively, as has been done through country case
studies.
Preliminary results
Comparative analysis of integration of disease
control programmes into the general health system
in four countries of South East Asia
Analyses through case studies offer insights, as Pawson and
Tilley suggest, into what, why and how programmes and health
systems work. Comparative analyses have the potential to offer
additional insights. Ecological analyses draw upon aggregated
data from groups of cases to make inferences about relation-
ships, and can be considered a form of multi-level modelling
(Steel et al. 2006). We present preliminary ecological analyses of
disease outcomes associated with Global Fund investments and
issues which are associated with wider health system strength-
ening in order to explore and illustrate relationships that may
exist between investments in programmes subject to substantial
financial support and the broader health impact on conditions
not associated with programme investment but, at least in part,
with wider health system functioning.
We briefly illustrate such an ecological approach, correlating
Global Fund investments with an output of TB control
programmes (as an illustration of a programme specific
outcome, TB detection rates) and with under-5 mortality rates
as an outcome dependent upon wider health system func-
tioning (Figures 5 and 6). Figure 5 suggests there is little
correlation to date between the total sum of disbursed Global
Fund investments and TB case detection rates. This may be the
result of several factors, including increased investments
leading to increased clinical awareness, strengthened surveil-
lance and higher rates of disease detection. Figure 6 shows
percentage changes in the under-5 mortality rate (wider health
system outcome) between the years 2000 and 2007, and the
total sum of approved Global Fund investments to-date. The
data indicate a weak association (correlation co-efficient 5.8)
between Global Fund investments and wider health outcomes,
as illustrated by reductions in under-5 mortality rates. This lack
of correlation may be a function of numerous influences
including funding for specifically targeting neonatal and child
health issues (for example, GAVI funding), immunization
coverage and overall increased health awareness, among others.
These simple ecological analyses suggest that further under-
standing of the relationships between investments and health
outcomes is necessary. We ask the question: is integration of
programme and health systems as a result of Global Fund
investments associated with improved health outcomes?
Integration score
The integration scores used in the analyses were derived from
data collected and collated as part of the country case studies,
for which methodological details are provided in Conseil et al.
(2010). In this study, country reports were re-evaluated by a
researcher not previously involved in the country case studies,
who scored each of the 25 elements of integration among
six health system functions according to the following scale:
‘not/predominantly not integrated’¼ 0; ‘partially integrated’¼ 1;
and ‘fully/predominantly integrated’¼ 2. Scores for each of the
six functions (stewardship and governance, finance, planning,
service delivery, monitoring and evaluation, and demand
Figure 5 Scatterplot showing total sum of disbursed Global Fund investments to date, measured in US$ (shows as Log of millions of US$), and
change in TB detection rate under DOTS, between the years 2000 and 2007.
DISEASE CONTROL PROGRAMMES AND HEALTH SYSTEMS INTEGRATION i27
generation) were then checked and confirmed by country case
study authors, and where amendments were necessary, this
was done by going back to the original data and re-evaluating
it in collaboration with country case study authors.
Overall aggregate scores were based on equal weights for the
integration of TB control programmes and HIV/AIDS control
programmes into the health system, as adjusting for disease
prevalence made little impact on the aggregate scores. Each
country had a final aggregate integration value ranging from 0
to 24, where higher values indicate greater integration. The
level and scope of integration of Global Fund-supported HIV
and TB control programmes into general health systems varied
widely across the country case studies we draw upon in this
analysis, from almost fully integrated (score 23), in Thailand, to
primarily vertical (score 6), in Vietnam (Conseil et al. 2010;
Desai et al. 2010; Hanvoravongchai et al. 2010; Mounier-Jack
et al. 2010; Rudge et al. 2010). These results are illustrated for
the health system overall and, as an illustration, for one public
health function—service delivery—which has been further
broken down into its specific elements (relating to infrastruc-
ture, humans resources, and procurement and supply systems)
for each of the countries (Tables 1 and 2).
Indeed, the level of integration across public health functions
in the four countries indicated that certain health functions
tended to show similar patterns of integration. For instance,
monitoring and evaluation (M&E) for HIV and TB was weakly
integrated within the overall M&E system (with the exception
of Thailand), due in part to specific requirements of donors.
Similarly, the financing function of HIV and TB programmes
was typically weakly integrated with general health system
financing. Conversely, service delivery and demand generation
for both HIV/AIDS control and TB control were partially or fully
(in the case of Thailand) integrated into the health system
in each of the case studies. Where demand generation for
disease-specific programmes was not fully integrated, this
tended to be either because providers were non-governmental
organizations (NGOs), or because the general health care
system failed to reach the target population, as is the case for
most-at-risk groups for HIV. By contrast, comparison of disease
control programme service delivery showed that human re-
sources and infrastructure tended to be partly, or sometimes
fully, integrated within general health services, particularly at
decentralized levels and when disease prevalence was relatively
high, as seen in the case of TB in Indonesia, Lao PDR and PNG.
At the front-line level, multi-functional personnel often de-
livered comprehensive care to patients, including those targeted
by the disease control programmes.
Integration and its association with health
outcomes
To test the assumption that changes in health outcomes are
associated with differences in the degree of integration of
cross-programme and programme-system health system func-
tions, we compare changes in under-5 mortality rates with
funds disbursed by the Global Fund, without incorporating
integration values (Figure 7a) and then by adjusting per unit of
integration according to the scores calculated for each country,
as described above (Figure 7b). Figure 7a shows a positive but
fairly weak association between Global Fund investment and
change in under-5 mortality rates, with an R2 value of 0.383
indicating that a large proportion of variation in the data
among these five countries remains unexplained. When this
relationship was further explored by incorporating a variable
corresponding to the relative level of integration between
disease control programmes and the health system, we found
that the correlation co-efficient decreased substantially
(R2¼ 0.074) (Figure 7b). This decrease corresponds to vari-
ations in the relative position of the countries along the y axes,
with Vietnam now seeming to be an outlier. Thus, at least in
this preliminary analysis, increased levels of aggregate integra-
tion of health systems and programmes is not associated with
Figure 6 Scatterplot showing total sum of disbursed Global Fund investments to date, measured in US$ (shows as Log of millions of US$), and
percentage reduction in national under-5 mortality rate, between the years 2000 and 2007.
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improving outcomes associated with increasing Global Fund
investments. Why Vietnam is such an outlier in this analysis is
unclear and could be the focus of further analysis.
Although this example of an ecological analysis exploring the
apparent impact of integration of health systems is necessarily
limited by a small number of case studies, this approach
could be taken further in order to yield valuable insights. For
example, analyses of all 140 countries, where programmatic
output and health outcome data exist along with donor
investment might be expanded to explore correlations between
absolute financing, proportion of health budget spending on
programmes, proportion of donor funding on programmes
and trends in financing, among other investment variables,
and their associations with integration by health system
function. As data on integration become available along with
a harmonized metric, a series of additional quantitative
ecological analyses could be undertaken to determine, at a
granular level, associations between both aggregate scores of
integration and also disaggregated scores of key functions,
investments and health outcomes. Correlation of alternative
health outputs and outcomes could be expanded and include,
for example, programme-specific health outputs, non-pro-
gramme-specific outcomes such as avoidable mortality, mater-
nal mortality, neonatal mortality and/or with trends in the
above, over time.
Such analyses will likely result in plausible models for
integration, and the programmatic and non-programmatic
benefits that appear to be associated, as well as testable
hypotheses related to health systems and integration.
Conclusion
Interest in health systems analysis and in the comparative
analysis of health systems has grown over the past decade and
has gained increased urgency with investments from new
institutions and the shifting global health governance architec-
ture. Questions regarding what works, where, why and how
are critically important for all interested parties and answers
are necessary if public health systems are to function most
effectively to achieve desired public health goals. Most studies
to-date on health systems and communicable disease control
have been limited, especially when addressing the issue of
integration of functions between vertical disease control pro-
grammes and horizontal health systems.
We have attempted to offer here an approach that builds
upon a body of work that has informed country case study
conduct, and build upon a wider debate surrounding notions
of integration. We acknowledge that there are limitations
to comparative analyses of case studies. This is, however, an
attempt to support the further development of an analytical
approach in a pragmatic manner, offering what we hope are
important insights to inform improved health investments and
ultimately to improve public health outcomes.
Table 1 Scoring for disease control programme–health system integration, using data from country case studies (Indonesia, Lao PDR, Papua
New Guinea, Thailand) and Vietnam. Aggregate scores correspond to a sum of TB control programme–health system integration and HIV control
programme–health system integration, where 0¼no integration, 1¼ partial integration and 2¼ full integration for each of the programmes
Country
Health system function
Stewardship &
governance Finance Planning
Service
delivery
Monitoring &
evaluation
Demand
generation
Aggregate
system score*
Indonesia 2 1 2 2 1 2 10
Lao PDR 2 0 2 2 2 2 10
Papua New Guinea 2 2 2 2 0 2 10
Thailand 4 4 4 4 4 3 23
Vietnam 1 0 0 2 1 2 6
*Aggregate score based on equal weights for the integration of TB control programmes and HIV/AIDS control programmes into the health system.
When adjusted for disease prevalence, this made little impact on the aggregate score. As total disbursed funds do not always correspond to disease burdens,
we did not weight according to funding.
Table 2 Aggregate scoring for one health system function (service delivery) using data from country case studies (Indonesia, Lao PDR, Papua
New Guinea, Thailand) and Vietnam. Component scores correspond to level of programme–system integration, where 0¼no integration, 1¼ partial
integration and 2¼ full integration for each of the components. Aggregate function scores correspond to a sum of component scores, where
0–2¼no integration, 3–5¼ partial integration and 6–8¼ full integration
Country
Service delivery variable
Human
resources
Shared
infrastructure
Laboratory
services
Drug supply
management
Aggregate
function score*
Indonesia 1 1 1 1 4
Lao PDR 1 1 1 0 3
Papua New Guinea 2 1 1 0 4
Thailand 2 2 2 2 8
Vietnam 1 2 0 1 4
*Component scores were given equal weights and summed to produce the aggregate score.
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Endnotes
1 For the purpose of this work, the definition of a health system is ‘a
set of relationships in which the structural components (means)
and their interactions are associated and connected to the goals the
system desires to achieve (ends)’ (Hsiao and Heller 2000).
2 Country case studies submitted in parallel with this article to this
supplement of Health Policy and Planning.
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GFATM investments to date, measured in US$, shown (a) without incorporating integration score and (b) when adjusted for integration score.
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